QQQ   309.36 (+1.90%)
AAPL   154.30 (+1.69%)
MSFT   267.90 (+4.33%)
META   190.98 (+2.64%)
GOOGL   107.11 (+4.09%)
AMZN   101.71 (-0.46%)
TSLA   195.34 (+0.30%)
NVDA   221.06 (+4.82%)
NIO   10.85 (-0.73%)
BABA   105.39 (-0.06%)
AMD   85.71 (+2.43%)
T   19.28 (-1.53%)
F   13.42 (+2.13%)
MU   61.92 (+3.23%)
CGC   2.81 (-4.75%)
GE   81.80 (-0.67%)
DIS   111.48 (+1.47%)
AMC   6.12 (-10.00%)
PFE   43.56 (-0.46%)
PYPL   83.07 (+0.90%)
NFLX   361.42 (-0.02%)
QQQ   309.36 (+1.90%)
AAPL   154.30 (+1.69%)
MSFT   267.90 (+4.33%)
META   190.98 (+2.64%)
GOOGL   107.11 (+4.09%)
AMZN   101.71 (-0.46%)
TSLA   195.34 (+0.30%)
NVDA   221.06 (+4.82%)
NIO   10.85 (-0.73%)
BABA   105.39 (-0.06%)
AMD   85.71 (+2.43%)
T   19.28 (-1.53%)
F   13.42 (+2.13%)
MU   61.92 (+3.23%)
CGC   2.81 (-4.75%)
GE   81.80 (-0.67%)
DIS   111.48 (+1.47%)
AMC   6.12 (-10.00%)
PFE   43.56 (-0.46%)
PYPL   83.07 (+0.90%)
NFLX   361.42 (-0.02%)
QQQ   309.36 (+1.90%)
AAPL   154.30 (+1.69%)
MSFT   267.90 (+4.33%)
META   190.98 (+2.64%)
GOOGL   107.11 (+4.09%)
AMZN   101.71 (-0.46%)
TSLA   195.34 (+0.30%)
NVDA   221.06 (+4.82%)
NIO   10.85 (-0.73%)
BABA   105.39 (-0.06%)
AMD   85.71 (+2.43%)
T   19.28 (-1.53%)
F   13.42 (+2.13%)
MU   61.92 (+3.23%)
CGC   2.81 (-4.75%)
GE   81.80 (-0.67%)
DIS   111.48 (+1.47%)
AMC   6.12 (-10.00%)
PFE   43.56 (-0.46%)
PYPL   83.07 (+0.90%)
NFLX   361.42 (-0.02%)
QQQ   309.36 (+1.90%)
AAPL   154.30 (+1.69%)
MSFT   267.90 (+4.33%)
META   190.98 (+2.64%)
GOOGL   107.11 (+4.09%)
AMZN   101.71 (-0.46%)
TSLA   195.34 (+0.30%)
NVDA   221.06 (+4.82%)
NIO   10.85 (-0.73%)
BABA   105.39 (-0.06%)
AMD   85.71 (+2.43%)
T   19.28 (-1.53%)
F   13.42 (+2.13%)
MU   61.92 (+3.23%)
CGC   2.81 (-4.75%)
GE   81.80 (-0.67%)
DIS   111.48 (+1.47%)
AMC   6.12 (-10.00%)
PFE   43.56 (-0.46%)
PYPL   83.07 (+0.90%)
NFLX   361.42 (-0.02%)
NASDAQ:BWAY

BrainsWay - BWAY Stock Forecast, Price & News

$2.00
-0.03 (-1.48%)
(As of 02/7/2023 03:40 PM ET)
Add
Compare
Today's Range
$1.98
$2.01
50-Day Range
$1.73
$2.47
52-Week Range
$1.64
$9.18
Volume
32,012 shs
Average Volume
79,396 shs
Market Capitalization
$33.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.19

BrainsWay MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
359.4% Upside
$9.19 Price Target
Short Interest
Healthy
0.39% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.27mentions of BrainsWay in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.41) to ($0.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Medical Sector

157th out of 1,029 stocks

Surgical & Medical Instruments Industry

15th out of 105 stocks

BWAY stock logo

About BrainsWay (NASDAQ:BWAY) Stock

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BrainsWay and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

BrainsWay's (BWAY) Buy Rating Reaffirmed at HC Wainwright
GRAPHITE: "Essential for America's National Defense"
Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider.
BrainsWay Resolves Neuronetics Litigation
GRAPHITE: "Essential for America's National Defense"
Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider.
What to See on Broadway in October
See More Headlines
Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BrainsWay and its competitors with MarketBeat's FREE daily newsletter.

BWAY Company Calendar

Last Earnings
11/16/2022
Today
2/07/2023
Next Earnings (Estimated)
3/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BWAY
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.19
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$3.75
Forecasted Upside/Downside
+359.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-6,460,000.00
Pretax Margin
-36.95%

Debt

Sales & Book Value

Annual Sales
$29.66 million
Book Value
$3.48 per share

Miscellaneous

Free Float
13,396,000
Market Cap
$33.08 million
Optionable
Not Optionable
Beta
0.97

Key Executives

  • Christopher R. von Jako
    President & Chief Executive Officer
  • Hadar Levy
    Chief Operating Officer & Senior Vice President
  • Richard Scott Areglado
    Chief Financial Officer & Senior Vice President
  • Yiftach Roth
    Chief Scientific Officer
  • Moria Ankri
    Vice President-Research & Development













BWAY Stock - Frequently Asked Questions

Should I buy or sell BrainsWay stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BWAY shares.
View BWAY analyst ratings
or view top-rated stocks.

What is BrainsWay's stock price forecast for 2023?

4 analysts have issued 12-month price objectives for BrainsWay's stock. Their BWAY share price forecasts range from $3.75 to $15.00. On average, they anticipate the company's share price to reach $9.19 in the next twelve months. This suggests a possible upside of 353.1% from the stock's current price.
View analysts price targets for BWAY
or view top-rated stocks among Wall Street analysts.

How have BWAY shares performed in 2023?

BrainsWay's stock was trading at $2.47 at the start of the year. Since then, BWAY stock has decreased by 17.9% and is now trading at $2.0275.
View the best growth stocks for 2023 here
.

When is BrainsWay's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 8th 2023.
View our BWAY earnings forecast
.

How were BrainsWay's earnings last quarter?

BrainsWay Ltd. (NASDAQ:BWAY) released its quarterly earnings results on Wednesday, November, 16th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.08. The company earned $5.17 million during the quarter, compared to analyst estimates of $8.52 million. BrainsWay had a negative net margin of 36.57% and a negative trailing twelve-month return on equity of 20.09%.

What other stocks do shareholders of BrainsWay own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BrainsWay investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Pfizer (PFE), Neuronetics (STIM), Boingo Wireless (WIFI), Ampio Pharmaceuticals (AMPE), Eastman Chemical (EMN), Enbridge (ENB) and Energy Transfer (ET).

When did BrainsWay IPO?

(BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO.

What is BrainsWay's stock symbol?

BrainsWay trades on the NASDAQ under the ticker symbol "BWAY."

Who are BrainsWay's major shareholders?

BrainsWay's stock is owned by many different retail and institutional investors. Top institutional investors include Taylor Frigon Capital Management LLC (1.15%).

How do I buy shares of BrainsWay?

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BrainsWay's stock price today?

One share of BWAY stock can currently be purchased for approximately $2.03.

How much money does BrainsWay make?

BrainsWay (NASDAQ:BWAY) has a market capitalization of $33.53 million and generates $29.66 million in revenue each year. The company earns $-6,460,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

How can I contact BrainsWay?

BrainsWay's mailing address is 19 HARTUM STREET BYNET BUILDING 3RD FL Har HaHotzvim, Jerusalem L3, 9777518. The official website for the company is www.brainsway.com. The company can be reached via phone at (722) 582-4030 or via email at hadarl@brainsway.com.

This page (NASDAQ:BWAY) was last updated on 2/7/2023 by MarketBeat.com Staff